{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:11:49Z","timestamp":1768007509005,"version":"3.49.0"},"reference-count":49,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11,1]]},"abstract":"<jats:p>BACKGROUND: The long-term consequences of inhaled nitric oxide (iNO) use in premature newborns with respiratory failure are unknown. We therefore studied the clinical and economic outcomes to 1 year of corrected age after a randomized controlled trial of prophylactic iNO.<\/jats:p><jats:p>METHODS: Premature newborns (gestational age \u226434 w, birth weight 500\u20131250 g) with respiratory failure randomly received 5 ppm iNO or placebo within 48 h of birth until 21 d or extubation. We assessed clinical outcomes via in-person neurodevelopmental evaluation at 1 y corrected age and telephone interviews every 3 m. We estimated costs from detailed hospital bills and interviews, converting all costs to 2008 US$. Of 793 trial subjects, 631 (79.6%) contributed economic data, and 455 (77.1% of survivors) underwent neurodevelopmental evaluation.<\/jats:p><jats:p>RESULTS: At 1 y corrected age, survival was not different by treatment arm (79.2% iNO vs. 74.5% placebo, P = .12), nor were other post-discharge outcomes. For subjects weighing 750\u2013999 g, those receiving iNO had greater survival free from neurodevelopmental impairment (67.9% vs. 55.6%, P = .04). However, in subjects weighing 500\u2013749 g, iNO led to greater oxygen dependency (11.7% vs. 4.0%, P = .04). Median total costs were similar ($235 800 iNO vs. $198 300 placebo, P = .19). Quality-adjusted survival was marginally better with iNO (by 0.011 quality-adjusted life-years\/subject). The incremental cost-effectiveness ratio was $2.25 million\/quality-adjusted life-year.<\/jats:p><jats:p>CONCLUSIONS: Subjects in both arms commonly experienced neurodevelopmental and pulmonary morbidity, consuming substantial health care resources. Prophylactic iNO beginning in the first days of life did not lower costs and had a poor cost-effectiveness profile.<\/jats:p>","DOI":"10.1542\/peds.2009-0114","type":"journal-article","created":{"date-parts":[[2009,10,20]],"date-time":"2009-10-20T01:25:57Z","timestamp":1256001957000},"page":"1333-1343","source":"Crossref","is-referenced-by-count":30,"title":["Clinical and Economic Effects of iNO in Premature Newborns With Respiratory Failure at 1 Year"],"prefix":"10.1542","volume":"124","author":[{"given":"R. Scott","family":"Watson","sequence":"first","affiliation":[{"name":"Clinical Research, Investigation, and Systems Modeling of Acute Illness Laboratory, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Clermont","sequence":"additional","affiliation":[{"name":"Clinical Research, Investigation, and Systems Modeling of Acute Illness Laboratory, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Kinsella","sequence":"additional","affiliation":[{"name":"Pediatric Heart Lung Center, University of Colorado School of Medicine\/Children's Hospital, Denver, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Kong","sequence":"additional","affiliation":[{"name":"Clinical Research, Investigation, and Systems Modeling of Acute Illness Laboratory, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"},{"name":"Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Arendt","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Ohio State University School of Medicine, Columbus, Ohio"},{"name":"Research Institute of Nationwide Children's Hospital, Columbus, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Cutter","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Alabama, Birmingham, Alabama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter T.","family":"Linde-Zwirble","sequence":"additional","affiliation":[{"name":"ZD Associates, Perkasie, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven H.","family":"Abman","sequence":"additional","affiliation":[{"name":"Pediatric Heart Lung Center, University of Colorado School of Medicine\/Children's Hospital, Denver, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek C.","family":"Angus","sequence":"additional","affiliation":[{"name":"Clinical Research, Investigation, and Systems Modeling of Acute Illness Laboratory, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Prolonged Outcomes After Nitric Oxide Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2009,11,1]]},"reference":[{"key":"2021120905200822300_R1","doi-asserted-by":"crossref","unstructured":"Kinsella JP, Cutter GR, Walsh WF, et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med.\u20082006;355(4):354\u2013364","DOI":"10.1056\/NEJMoa060442"},{"key":"2021120905200822300_R2","unstructured":"Kanwar S, Kubes P. Nitric oxide is an antiadhesive molecule for leukocytes. New Horiz.\u20081995;3(1):93\u2013104"},{"key":"2021120905200822300_R3","doi-asserted-by":"crossref","unstructured":"Kinsella JP, Ivy DD, Abman SH. Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease. Pediatr Res.\u20081994;36(3):402\u2013408","DOI":"10.1203\/00006450-199409000-00022"},{"key":"2021120905200822300_R4","doi-asserted-by":"crossref","unstructured":"Kinsella JP, Parker TA, Galan H, Sheridan BC, Halbower AC, Abman SH. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res.\u20081997;41(4 pt 1):457\u2013463","DOI":"10.1203\/00006450-199704000-00002"},{"key":"2021120905200822300_R5","doi-asserted-by":"crossref","unstructured":"Gutierrez HH, Nieves B, Chumley P, Rivera A, Freeman BA. Nitric oxide regulation of superoxide-dependent lung injury: oxidant-protective actions of endogenously produced and exogenously administered nitric oxide. Free Radic Biol Med.\u20081996;21(1):43\u201352","DOI":"10.1016\/0891-5849(95)02226-0"},{"key":"2021120905200822300_R6","doi-asserted-by":"crossref","unstructured":"Ballard PL, Merrill JD, Truog WE, et al. Surfactant function and composition in premature infants treated with inhaled nitric oxide. Pediatrics.\u20082007;120(2):346\u2013353","DOI":"10.1542\/peds.2007-0095"},{"key":"2021120905200822300_R7","doi-asserted-by":"crossref","unstructured":"Ballard PL, Gonzales LW, Godinez RI, et al. Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide. Pediatr Res.\u20082006;59(1):157\u2013162 Jan","DOI":"10.1203\/01.pdr.0000190664.69081.f1"},{"key":"2021120905200822300_R8","doi-asserted-by":"crossref","unstructured":"Gong X, Guo C, Huang S, Sun B. Inhaled nitric oxide alleviates hyperoxia suppressed phosphatidylcholine synthesis in endotoxin-induced injury in mature rat lungs. Respir Res.\u20082006;7:5","DOI":"10.1186\/1465-9921-7-5"},{"key":"2021120905200822300_R9","doi-asserted-by":"crossref","unstructured":"McCurnin DC, Pierce RA, Chang LY, et al. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol.\u20082005;288(3):L450\u2013L459","DOI":"10.1152\/ajplung.00347.2004"},{"key":"2021120905200822300_R10","doi-asserted-by":"crossref","unstructured":"Lin YJ, Markham NE, Balasubramaniam V, et al. Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res.\u20082005;58(1):22\u201329","DOI":"10.1203\/01.PDR.0000163378.94837.3E"},{"key":"2021120905200822300_R11","doi-asserted-by":"crossref","unstructured":"Bland RD, Albertine KH, Carlton DP, MacRitchie AJ. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med.\u20082005;172(7):899\u2013906","DOI":"10.1164\/rccm.200503-384OC"},{"key":"2021120905200822300_R12","doi-asserted-by":"crossref","unstructured":"Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med.\u20081997;336(9):597\u2013604","DOI":"10.1056\/NEJM199702273360901"},{"key":"2021120905200822300_R13","doi-asserted-by":"crossref","unstructured":"Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med.\u20082000;342(7):469\u2013474","DOI":"10.1056\/NEJM200002173420704"},{"key":"2021120905200822300_R14","doi-asserted-by":"crossref","unstructured":"Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med.\u20082003;349(22):2099\u20132107","DOI":"10.1056\/NEJMoa031154"},{"key":"2021120905200822300_R15","doi-asserted-by":"crossref","unstructured":"Ballard RA, Truog WE, Cnaan A, et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med.\u20082006;355(4):343\u2013353","DOI":"10.1056\/NEJMoa061088"},{"key":"2021120905200822300_R16","doi-asserted-by":"crossref","unstructured":"Kinsella JP, Walsh WF, Bose CL, et al. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet.\u20081999;354(9184):1061\u20131065","DOI":"10.1016\/S0140-6736(99)03558-8"},{"key":"2021120905200822300_R17","doi-asserted-by":"crossref","unstructured":"Van Meurs KP, Wright LL, Ehrenkranz RA, et al. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med.\u20082005;353(1):13\u201322","DOI":"10.1056\/NEJMoa043927"},{"key":"2021120905200822300_R18","doi-asserted-by":"crossref","unstructured":"Whittle J, Lin CJ, Lave JR, et al. Relationship of provider characteristics to outcomes, process, and costs of care for community-acquired pneumonia. Med Care.\u20081998;36(7):977\u2013987","DOI":"10.1097\/00005650-199807000-00005"},{"key":"2021120905200822300_R19","doi-asserted-by":"crossref","unstructured":"Ellis SG, Miller DP, Brown KJ, et al. In-hospital cost of percutaneous coronary revascularization: critical determinants and implications. Circulation.\u20081995;92(4):741\u2013747","DOI":"10.1161\/01.CIR.92.4.741"},{"key":"2021120905200822300_R20","unstructured":"Rogowski J, Harrison E. Treatment Costs for Very Low Birth Weight Infants. Santa Monica, CA: Rand Corporation; 1995. Report No. MR-451-AHCPR"},{"key":"2021120905200822300_R21","doi-asserted-by":"crossref","unstructured":"Angus DC, Musthafa AA, Clermont G, et al. Quality-adjusted survival in the first year after the acute respiratory distress syndrome. Am J Respir Crit Care Med.\u20082001;163(6):1389\u20131394","DOI":"10.1164\/ajrccm.163.6.2005123"},{"key":"2021120905200822300_R22","doi-asserted-by":"crossref","unstructured":"Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making.\u20081993;13(2):89\u2013102","DOI":"10.1177\/0272989X9301300202"},{"key":"2021120905200822300_R23","doi-asserted-by":"crossref","unstructured":"Angus DC, Clermont G, Watson RS, Linde-Zwirble WT, Clark RH, Roberts MS. Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States. Pediatrics.\u20082003;112(6 pt 1):1351\u20131360","DOI":"10.1542\/peds.112.6.1351"},{"key":"2021120905200822300_R24","doi-asserted-by":"crossref","unstructured":"Lorch SA, Cnaan A, Barnhart K. Cost-effectiveness of inhaled nitric oxide for the management of persistent pulmonary hypertension of the newborn. Pediatrics.\u20082004;114(2):417\u2013426","DOI":"10.1542\/peds.114.2.417"},{"key":"2021120905200822300_R25","doi-asserted-by":"crossref","unstructured":"Victorian Infant Collaborative Study Group. Economic outcome for intensive care of infants of birth weight 500\u2013999 g born in Victoria in the post surfactant era. J Paediatr Child Health.\u20081997;33(3):202\u2013208","DOI":"10.1111\/j.1440-1754.1997.tb01580.x"},{"key":"2021120905200822300_R26","doi-asserted-by":"crossref","unstructured":"Saigal S, Stoskopf BL, Feeny D, et al. Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents. JAMA.\u20081999;281(21):1991\u20131997","DOI":"10.1001\/jama.281.21.1991"},{"key":"2021120905200822300_R27","doi-asserted-by":"crossref","unstructured":"Oostenbrink R, Maas M, Moons KG, Moll HA. Sequelae after bacterial meningitis in childhood. Scand J Infect Dis.\u20082002;34(5):379\u2013382","DOI":"10.1080\/00365540110080179"},{"key":"2021120905200822300_R28","doi-asserted-by":"crossref","unstructured":"Feeny D, Furlong W, Torrance GW, et al. Multi-attribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care.\u20082002;40(2):113\u2013128","DOI":"10.1097\/00005650-200202000-00006"},{"key":"2021120905200822300_R29","unstructured":"Bureau of Labor Statistics. Unpublished Tabulations From the Current Population Survey, 2000. Washington, DC: Bureau of Labor Statistics; 2000"},{"key":"2021120905200822300_R30","unstructured":"Haddix AC, Teutsch SM, Shaffer PA, Dunet DO. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. New York, NY: Oxford University Press; 1996"},{"key":"2021120905200822300_R31","doi-asserted-by":"crossref","unstructured":"Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996","DOI":"10.1093\/oso\/9780195108248.001.0001"},{"key":"2021120905200822300_R32","doi-asserted-by":"crossref","unstructured":"Angus DC, Rubenfeld GD, Roberts MS, et al. Understanding costs and cost-effectiveness in critical care: report from the Second American Thoracic Society Workshop on Outcomes Research. Am J Respir Crit Care Med.\u20082002;165(4):540\u2013550","DOI":"10.1164\/ajrccm.165.4.16541"},{"key":"2021120905200822300_R33","unstructured":"Consumer Price Indexes. US Department of Labor, Bureau of Labor Statistics. Available at: www.bls.gov\/cpi\/home.htm. Accessed October 25, 2008"},{"key":"2021120905200822300_R34","doi-asserted-by":"crossref","unstructured":"Hintz SR, Van Meurs KP, Perritt R, et al. Neurodevelopmental outcomes of premature infants with severe respiratory failure enrolled in a randomized, controlled trial of inhaled nitric oxide. J Pediatr.\u20082007;151(1):16\u201322","DOI":"10.1016\/j.jpeds.2007.03.017"},{"key":"2021120905200822300_R35","doi-asserted-by":"crossref","unstructured":"Mestan KK, Marks JD, Hecox K, Huo D, Schreiber MD. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med.\u20082005;353(1):23\u201332","DOI":"10.1056\/NEJMoa043514"},{"key":"2021120905200822300_R36","unstructured":"Owens PL, Thompson J, Elixhauser A, Ryan K. Care of Children and Adolescents in US Hospitals. Rockville, MD: Agency for Healthcare Research and Quality; 2003. Agency for Healthcare Research and Quality publication No 04-0004"},{"key":"2021120905200822300_R37","doi-asserted-by":"crossref","unstructured":"Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled?Ann Intern Med.\u20081996;125(7):605\u2013613","DOI":"10.7326\/0003-4819-125-7-199610010-00011"},{"key":"2021120905200822300_R38","doi-asserted-by":"crossref","unstructured":"Prentice RL. Surrogate end points in clinical trials: definition and operational criteria. Stat Med.\u20081989;8(4):431\u2013440","DOI":"10.1002\/sim.4780080407"},{"key":"2021120905200822300_R39","doi-asserted-by":"crossref","unstructured":"High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants: assessment of pulmonary function at 9 months of corrected age. HiFi Study Group. J Pediatr.\u20081990;116(6):933\u2013941","DOI":"10.1016\/S0022-3476(05)80657-2"},{"key":"2021120905200822300_R40","doi-asserted-by":"crossref","unstructured":"Garland JS, Alex CP, Pauly TH, et al. A 3-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial. Pediatrics.\u20081999;104(1 pt 1):91\u201399","DOI":"10.1542\/peds.104.1.91"},{"key":"2021120905200822300_R41","doi-asserted-by":"crossref","unstructured":"Shinwell ES, Karplus M, Reich D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed.\u20082000;83(3):F177\u2013F181","DOI":"10.1136\/fn.83.3.F177"},{"key":"2021120905200822300_R42","doi-asserted-by":"crossref","unstructured":"O'Shea TM, Kothadia JM, Klinepeter KL, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics.\u20081999;104(1 pt 1):15\u201321","DOI":"10.1542\/peds.104.1.15"},{"key":"2021120905200822300_R43","doi-asserted-by":"crossref","unstructured":"Holling EE, Leviton A. Characteristics of cranial ultrasound white-matter echolucencies that predict disability: a review. Dev Med Child Neurol.\u20081999;41(2):136\u2013139","DOI":"10.1017\/S0012162299000262"},{"key":"2021120905200822300_R44","doi-asserted-by":"crossref","unstructured":"Pierrat V, Duquennoy C, van HI, Ernst M, Guilley N, de Vries LS. Ultrasound diagnosis and neurodevelopmental outcome of localised and extensive cystic periventricular leucomalacia. Arch Dis Child Fetal Neonatal Ed.\u20082001;84(3):F151\u2013F156","DOI":"10.1136\/fn.84.3.F151"},{"key":"2021120905200822300_R45","doi-asserted-by":"crossref","unstructured":"O'Shea TM, Klinepeter KL, Dillard RG. Prenatal events and the risk of cerebral palsy in very low birth weight infants. Am J Epidemiol.\u20081998;147(4):362\u2013369","DOI":"10.1093\/oxfordjournals.aje.a009458"},{"key":"2021120905200822300_R46","doi-asserted-by":"crossref","unstructured":"Ment LR, Vohr B, Allan W, et al. Change in cognitive function over time in very low-birth-weight infants. JAMA.\u20082003;289(6):705\u2013711","DOI":"10.1001\/jama.289.6.705"},{"key":"2021120905200822300_R47","doi-asserted-by":"crossref","unstructured":"Walsh MC, Yao Q, Gettner P, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics.\u20082004;114(5):1305\u20131311","DOI":"10.1542\/peds.2004-0204"},{"key":"2021120905200822300_R48","unstructured":"Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: How good a basis for estimating costs?Inquiry.\u20081995;32(4):476\u2013481"},{"key":"2021120905200822300_R49","doi-asserted-by":"crossref","unstructured":"Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine: reporting of subgroup analyses in clinical trials. N Engl J Med.\u20082007;357(21):2189\u20132194","DOI":"10.1056\/NEJMsr077003"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/124\/5\/1333\/1009837\/zpe01109001333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/124\/5\/1333\/1009837\/zpe01109001333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T06:11:13Z","timestamp":1710655873000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/124\/5\/1333\/72165\/Clinical-and-Economic-Effects-of-iNO-in-Premature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,1]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,11,1]]},"published-print":{"date-parts":[[2009,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2009-0114","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,1]]}}}